Cyclin-dependent kinase inhibitors exert distinct effects on patient-derived 2D and 3D glioblastoma cell culture models

Current therapeutic approaches have met limited clinical success for glioblastoma multiforme (GBM). Since GBM harbors genomic alterations in cyclin-dependent kinases (CDKs), targeting these structures with specific inhibitors (CDKis) is promising. Here, we describe the antitumoral potential of selec...

Descripción completa

Detalles Bibliográficos
Autores principales: Riess, Christin, Koczan, Dirk, Schneider, Björn, Linke, Charlotte, del Moral, Katharina, Classen, Carl Friedrich, Maletzki, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961149/
https://www.ncbi.nlm.nih.gov/pubmed/33723248
http://dx.doi.org/10.1038/s41420-021-00423-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961149/
https://www.ncbi.nlm.nih.gov/pubmed/33723248
http://dx.doi.org/10.1038/s41420-021-00423-1

Ejemplares similares